Article Sidebar

Download
PDF

Main Article Content

Abstract

RÉSUMÉ
Introduction. le vaccin pentavalent DTC-HepB-Hib est un vaccin contenant 5 autres vaccins à savoir les vaccins contre la tuberculose (BCG), la diphtérie, le tétanos, la coqueluche, l’Hépatite B et l’Haemophilus influenzae type b. Dans la commune III du district de Bamako, la couverture en Penta 3 reste faible comparée à celle du Penta 1 et du Penta 2. Le but de cette étude était d’étudier Perception des médecins sur les déterminants de la non-observance de la population à la prise du vaccin Penta 3 dans la commune III du district de Bamako. Méthodologie. Une étude qualitative exploratoire, impliquant des entretiens individuels, a été conduite à Bamako entre le 1er Juillet et le 30 Aout 2019 auprès de 12 médecins du système de santé malien et de l’Organisation mondiale de la santé. Les entretiens ont été conduits avec l’aide d’un guide d’entretien, enregistrés, transcrits puis analysés de manière thématique. Résultats. Notre enquête a été réalisée auprès de 12 médecins avec comme tranche d’âge la plus représentée celle de 30 à 50 ans (50.0%) et une prédominance masculine (75%). La présence chez l’enfant de fièvre, douleur, inflammation et impotence fonctionnelle du membre inférieur après le vaccin décourageait les mères à continuer la prise de celui ci. Le retard, l’absentéisme et le mauvais accueil des mères d’enfants par les agents de vaccination affectaient l’intérêt de celle-ci pour le vaccin. Le mode d’administration du vaccin, le nombre de dose du vaccin, la gestion des temps d’attente, la gestion des effets secondaires, l’insuffisance des ressources financières, les difficultés à rentrer en contact avec les femmes et la gestion des jours de vaccination étaient des freins à la poursuivre de la vaccination. Conclusion. Selon les médecins les déterminants de non observance du vaccin Penta 3 étaient essentiellement les effets secondaires du vaccin chez l’enfant, les attitudes des agents de vaccination envers les mères et le niveau éducatif et économique des populations.
ABSTRACT
Introduction. The pentavalent DTC-HepB-Hib vaccine is a vaccine containing 5 other vaccines, namely vaccines against tuberculosis (BCG), diphtheria, tetanus, pertussis, Hepatitis B, and Haemophilus influenzae type b. In the commune III of the Bamako district, the coverage of Penta 3 remains low compared to that of Penta 1 and Penta 2. The aim of this study was to investigate the perception of physicians on the determinants of non-compliance of the population in taking the Penta 3 vaccine in the commune III of the Bamako district. Methodology. An exploratory qualitative study involving individual interviews was conducted in Bamako between July 1st and August 30th, 2019 with 12 physicians from the Malian health system and the World Health Organization. The interviews were conducted with the help of an interview guide, recorded, transcribed, and then analyzed thematically. Results. Our survey was conducted with 12 physicians, with the most represented age group being 30 to 50 years old (50.0%) and a male predominance (75%). The presence of fever, pain, inflammation, and functional impairment of the lower limb in children after the vaccine discouraged mothers from continuing its administration. Delays, absenteeism, and poor reception of mothers by vaccination agents affected their interest in the vaccine. The mode of vaccine administration, the number of vaccine doses, waiting time management, side effects management, lack of financial resources, difficulties in contacting women, and vaccination day management were barriers to continued vaccination. Conclusion. According to the physicians, the main determinants of non-compliance with the Penta 3 vaccine were primarily the side effects of the vaccine in children, the attitudes of vaccination agents towards mothers, and the educational and economic level of the populations.

Keywords

perception médécins déterminants observance vaccin penta 3 Bamako Mali Perception physician determinants observance penta 3 Bamako Mali

Article Details

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

How to Cite
Birama Apho Ly, Fatoumata Bintou Traoré, Cheick Abou Coulibaly, Abdoulaye Dembélé, Abdoulaye Guindo, Ndeye Lallah Nina Koite, Issa Diallo, Hawa Niélé Diara, Lalla Fatouma Traoré, Mohamed Ali Ag Ahmed, Mohamed Touré, Yacouba Cissoko, & Samba Diop. (2024). Physicians’ Perception of the Determinants of Non-Adherence to the Penta 3 Vaccine among the Population in Bamako: A Qualitative Study. HEALTH SCIENCES AND DISEASE, 25(4). https://doi.org/10.5281/hsd.v25i4.5554
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX

References

  1. MacDonald NE. Vaccine hesitancy: Definition, scope and determinants. Vaccine. 14 août 2015;33(34):4161‑4.
  2. Aubry P, Alex Gaüzère B. Du Programme Élargi de Vaccinations aux Programmes Nationaux de Vaccination systématique. 2021.
  3. Kacem M, Dhouib W, Bennasrallah C, Zemni I, Abroug H, Ben Fredj M, et al. Expanded program of immunization in the Maghreb. Case study of Tunisia.Systematic review of the literature. Tunis Med. 1 oct 2018;96:696‑705.
  4. Loharikar A, Dumolard L, Chu S, Hyde T, Goodman T, Mantel C. Status of new vaccine introduction--worldwide, September 2016/Situation relative a l’introduction de nouveaux vaccins a l’echelle mondiale, Septembre 2016. Wkly Epidemiol Rec. 6 janv 2017;92(1):1‑9.
  5. Sangare AT. Etude des obstacles à la vaccination antitétanique chez les femmes en gestation au centre de référence de la commune V du District de Bamako. Rev Fr Econ Gest [Internet]. 15 oct 2021 [cité 2 janv 2023];2(10). Disponible sur: https://revuefreg.fr/index.php/home/article/view/390
  6. Suárez E, Asturias E, Hilbert A, Herzog C, Aeberhard U, Spyr C. A fully liquid DTPw-HepB-Hib combination vaccine for booster vaccination of toddlers in El Salvador. Rev Panam Salud Pública Pan Am J Public Health. 1 févr 2010;27:117‑24.
  7. K D. Problématiques de la couverture adéquate en penta 3 chez les enfants de 0-11mois dans le Centre de santé Communautaire et Universitaire de Konobougou, Mali. Mali Santé Publique. 2020;70‑5.
  8. Institut National de la Statistique ((INSTAT), Cellule de Planification et de Statistique du Secteur Santé-Développement Social et Promotion de la Famille (CPS/SS-DS-PF), The DHS Program, (ICF). Enquête Démographique et de Santé EDSM VI. 2019.
  9. Organisation mondiale de la Santé. Plan d’action mondial pour les vaccins 2011-2020 [Internet]. Global vaccine action plan 2011-2020. Genève: Organisation mondiale de la Santé; 2013 [cité 16 mars 2023]. 148 p. Disponible sur: https://apps.who.int/iris/handle/10665/79315
  10. Ministère de la santé et de l’action sociale, Direction de la Prévention. PLAN PLURIANNUEL COMPLET REVISE DE LA VACCINATION 2016-2020. 2015.
  11. Thorpe S, VanderEnde K, Peters C, Bardin L, Yount KM. The Influence of Women’s Empowerment on Child Immunization Coverage in Low, Lower-Middle, and Upper-Middle Income Countries: A Systematic Review of the Literature. Matern Child Health J. 1 janv 2016;20(1):172‑86.
  12. METCALF CJE, TATEM A, BJORNSTAD ON, LESSLER J, O’REILLY K, TAKAHASHI S, et al. Transport networks and inequities in vaccination: remoteness shapes measles vaccine coverage and prospects for elimination across Africa. Epidemiol Infect. mai 2015;143(7):1457‑66.
  13. Vidal Fuertes C, Johns NE, Goodman TS, Heidari S, Munro J, Hosseinpoor AR. The Association between Childhood Immunization and Gender Inequality: A Multi-Country Ecological Analysis of Zero-Dose DTP Prevalence and DTP3 Immunization Coverage. Vaccines. 27 juin 2022;10(7):1032.
  14. World Health Organization. Explorations of inequality: childhood immunization [Internet]. Geneva: World Health Organization; 2018 [cité 12 nov 2022]. Disponible sur: https://apps.who.int/iris/handle/10665/272864
  15. Yamey G. Scaling up global health interventions: a proposed framework for success. PLoS Med. juin 2011;8(6):e1001049.
  16. Guest G, Bunce A, Johnson L. How many interviews are enough? An experiment with data saturation and variability. Field Methods. 2006;18(1):59‑82.
  17. he costs of home delivery of a birth dose of hepatitis B vaccine in a prefilled syringe in Indonesia. Bull World Health Organ, 83(6), 456-461 - Google Search [Internet]. [cité 28 janv 2023].
  18. Paillé P, Mucchielli A. L’analyse qualitative en sciences humaines et sociales - 5e éd. Armand Colin; 2021. 410 p.
  19. White SE, Harvey SA, Meza G, Llanos A, Guzman M, Gamboa D, et al. Acceptability of a herd immunity-focused, transmission-blocking malaria vaccine in malaria-endemic communities in the Peruvian Amazon: an exploratory study. Malar J. 27 avr 2018;17:179.
  20. Karami M, Ameri P, Bathaei J, Berangi Z, Pashaei T, Zahiri A, et al. Adverse events following immunization with pentavalent vaccine: experiences of newly introduced vaccine in Iran. BMC Immunol. 23 août 2017;18(1):42.
  21. Hoyt J, Krishnaratne S, Hamon JK, Boudarene L, Chantler T, Demissie SD, et al. “As a woman who watches how my family is… I take the difficult decisions”: a qualitative study on integrated family planning and childhood immunisation services in five African countries. Reprod Health. 15 févr 2021;18(1):41.
  22. Chantler T, Karafillakis E, Wodajo S, Dechasa Demissie S, Sile B, Mohammed S, et al. « We All Work Together to Vaccinate the Child »: A Formative Evaluation of a Community-Engagement Strategy Aimed at Closing the Immunization Gap in North-West Ethiopia. Int J Environ Res Public Health. 3 avr 2018;15(4):667.
  23. Chantler T, Karafillakis E, Wodajo S, Dechasa Demissie S, Sile B, Mohammed S, et al. ‘We All Work Together to Vaccinate the Child’: A Formative Evaluation of a Community-Engagement Strategy Aimed at Closing the Immunization Gap in North-West Ethiopia. Int J Environ Res Public Health. 3 avr 2018;15(4):667.
  24. Hoyt J, Krishnaratne S, Hamon JK, Boudarene L, Chantler T, Demissie SD, et al. “As a woman who watches how my family is… I take the difficult decisions”: a qualitative study on integrated family planning and childhood immunisation services in five African countries. Reprod Health. déc 2021;18(1):41.
  25. White SE, Harvey SA, Meza G, Llanos A, Guzman M, Gamboa D, et al. Acceptability of a herd immunity-focused, transmission-blocking malaria vaccine in malaria-endemic communities in the Peruvian Amazon: an exploratory study. Malar J. déc 2018;17(1):179.
  26. Watson-Jones D, Mugo N, Lees S, Mathai M, Vusha S, Ndirangu G, et al. Access and Attitudes to HPV Vaccination amongst Hard-To-Reach Populations in Kenya. PLoS ONE. 26 juin 2015;10(6):e0123701.
  27. Domnich A, Cambiaggi M, Vasco A, Maraniello L, Ansaldi F, Baldo V, et al. Attitudes and Beliefs on Influenza Vaccination during the COVID-19 Pandemic: Results from a Representative Italian Survey. Vaccines. 30 nov 2020;8(4):711.
  28. Merten S, Schaetti C, Manianga C, Lapika B, Chaignat CL, Hutubessy R, et al. Local perceptions of cholera and anticipated vaccine acceptance in Katanga province, Democratic Republic of Congo. BMC Public Health. 22 janv 2013;13(1):60.
  29. Pugliese-Garcia M, Heyerdahl LW, Mwamba C, Nkwemu S, Chilengi R, Demolis R, et al. Factors influencing vaccine acceptance and hesitancy in three informal settlements in Lusaka, Zambia. Vaccine. 5 sept 2018;36(37):5617‑24.
  30. Abakar MF, Seli D, Lechthaler F, Schelling E, Tran N, Zinsstag J, et al. Vaccine hesitancy among mobile pastoralists in Chad: a qualitative study. Int J Equity Health. déc 2018;17(1):167.
  31. Fournet N, Mollema L, Ruijs WL, Harmsen IA, Keck F, Durand JY, et al. Under-vaccinated groups in Europe and their beliefs, attitudes and reasons for non-vaccination; two systematic reviews. BMC Public Health. déc 2018;18(1):196.
  32. Ababu Y, Braka F, Teka A, Getachew K, Tadesse T, Michael Y, et al. Behavioral determinants of immunization service utilization in Ethiopia: a cross-sectional community-based survey. Pan Afr Med J [Internet]. 2017 [cité 29 janv 2023];27(Suppl 2). Disponible sur: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5619917/
  33. Zahraei SM, Zamani G, Mohammadbeigi A, Asgarian A, Afrashteh S, Gharibnavaz H, et al. Estimation of the wastage rate of MMR and pentavalent vaccines in open and closed vials in three western provinces of Iran. Heliyon. 20 mai 2020;6(5):e04016.
  34. Organization World Health W. Monitoring vaccine wastage at country level: guidelines for programme managers. World Health Organization; 2005.
  35. Wallace AS, Willis F, Nwaze E, Dieng B, Sipilanyambe N, Daniels D, et al. Vaccine wastage in Nigeria: An assessment of wastage rates and related vaccinator knowledge, attitudes and practices. Vaccine. 4 déc 2017;35(48 Pt B):6751‑8.
  36. Kanagat N, Krudwig K, Wilkins KA, Kaweme S, Phiri G, Mwansa FD, et al. Health Care Worker Preferences and Perspectives on Doses per Container for 2 Lyophilized Vaccines in Senegal, Vietnam, and Zambia. Glob Health Sci Pract. 23 déc 2020;8(4):680‑8.
  37. Levin CE, Nelson CM, Widjaya A, Moniaga V, Anwar C. The costs of home delivery of a birth dose of hepatitis B vaccine in a prefilled syringe in Indonesia. Bull World Health Organ. juin 2005;83(6):456‑61.
  38. Drain PK, Nelson CM, Lloyd JS. Single-dose versus multi-dose vaccine vials for immunization programmes in developing countries. Bull World Health Organ. 2003;81(10):726‑31.

Most read articles by the same author(s)

Similar Articles

You may also start an advanced similarity search for this article.